Company Legal Name
Latest Valuation
Founded Year
Headquarter
Hyperliquid Labs operates a decentralized exchange specializing in perpetual futures trading, offering institutional-grade performance with significantly reduced fees compared to traditional centralized platforms. Founded in 2023 and headquartered in San Francisco, the company has positioned itself as a high-performance alternative in the decentralized finance space by combining the security benefits of decentralization with the speed and efficiency typically associated with centralized exchanges. The platform leverages advanced technology infrastructure to deliver low-latency trading experiences while maintaining full decentralization. Hyperliquid continues to focus on scaling its trading capabilities and expanding its derivative product offerings to capture growing institutional demand for decentralized trading solutions.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.





